Abstract:
Menorrhagia is defined as heavy menstrual bleeding that exceeds 80 mL per cycle.1
It is a common disorder that, on average, affects 30% of women.2 Having heavy periods significantly decreases women’s quality of life, requires time away from work, involves surgical intervention, including hysterectomy, and ultimately has a substantial cost impact on the healthcare system.3
Menorrhagia is a diagnosable ailment that needs to be treated to improve the quality of life of
affected women, however, a significant number of menorrhagia cases are classified as idiopathic. Research has shown that when women are dissatisfied with their normal therapy options, they frequently choose surgery, such as hysterectomy. These women might benefit from a specialized method of diagnosis and treatment that emphasizes pertinent coagulation parameters. A series of biochemical processes, known as the coagulation pathway, results in hemostasis. This complex pathway promotes healing and prevents spontaneous bleeding.
